Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Alinaghi, S. A. S. MohsseniPour, M. Saeidi, S. Habibi, P. Dashti, M. Nazarian, N. Noori, T. Pashaei, Z. Bagheri, A. B. Ghasemzadeh, A. Afsahi, A. M. Aghaie, N. Mojdeganlou, P. Arjmand, G. Zargari, G. Modiri, R. Mojdeganlou, H. Razi, A. Mehraeen, E. Dadras, O.

Complications of COVID-19 Vaccines during Pregnancy; a Systematic Review

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Huang, L. Y. Chiang, C. C. Li, Y. L. Lai, H. Y. Hsieh, Y. C. Wu, Y. H. Tsai, Y. Y.

Corneal Complications after COVID-19 Vaccination: A Systemic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Siahaan, Y. M. T. Hartoyo, V. Hariyanto, T. I. Kurniawan, A.

Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bronz, G. Faré, P. B. Lava, S. A. G. Bianchetti, M. G. Simonetti, G. D. Scoglio, M. Beretta-Piccoli, B. T. Agostoni, C. Milani, G. P.

Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Akumbom, A. M. Lee, J. J. Reynolds, N. R. Thayer, W. Wang, J. Slade, E.

Cost and effectiveness of HPV vaccine delivery strategies: A systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Meredith, N. R. Armstrong, E. P.

Cost-effectiveness of herpes zoster vaccines in the U.S.: A systematic review

  • Americas
  • United States of America
  • All age groups
  • Herpes zoster
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Zhou, L. Yan, W. Li, S. Yang, H. Zhang, X. Lu, W. Liu, J. Wang, Y.

Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Chan, K. S. K. Wong, C. H. L. Choi, H. C. W.

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ali, S. A. Bhattacharyya, S. Ahmad, F. N. Tiwari, R. V. C. Jain, T. Baad, S. R. Tiwari, H. D.

COVID Infections Breakthrough Post-Vaccination: Systematic Review

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mastan, S. Hodhody, G. Sajid, M. Malik, R. Charalambous, C. P.

COVID-19 Is Associated With a 4 Fold Increase in 30-day Mortality Risk in Hip Fracture Patients in the United Kingdom: A Systematic Review and Meta-analysis

  • Older adults
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...